JP2011513034A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011513034A5 JP2011513034A5 JP2010550818A JP2010550818A JP2011513034A5 JP 2011513034 A5 JP2011513034 A5 JP 2011513034A5 JP 2010550818 A JP2010550818 A JP 2010550818A JP 2010550818 A JP2010550818 A JP 2010550818A JP 2011513034 A5 JP2011513034 A5 JP 2011513034A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- component
- present
- chitosan
- bone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 50
- 229920001661 Chitosan Polymers 0.000 claims 31
- 229940045110 chitosan Drugs 0.000 claims 31
- 229920002674 hyaluronan Polymers 0.000 claims 27
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 25
- 210000000988 bone and bone Anatomy 0.000 claims 22
- 229960003160 hyaluronic acid Drugs 0.000 claims 21
- 210000002805 bone matrix Anatomy 0.000 claims 18
- 239000003795 chemical substances by application Substances 0.000 claims 14
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 13
- 230000002491 angiogenic effect Effects 0.000 claims 13
- 239000003173 antianemic agent Substances 0.000 claims 13
- 229920000615 alginic acid Polymers 0.000 claims 12
- 235000010443 alginic acid Nutrition 0.000 claims 12
- 229940072056 alginate Drugs 0.000 claims 11
- 102000003951 Erythropoietin Human genes 0.000 claims 10
- 108090000394 Erythropoietin Proteins 0.000 claims 10
- 229940105423 erythropoietin Drugs 0.000 claims 10
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 claims 10
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 claims 8
- 210000002449 bone cell Anatomy 0.000 claims 7
- 230000005754 cellular signaling Effects 0.000 claims 7
- 230000003394 haemopoietic effect Effects 0.000 claims 7
- 230000011664 signaling Effects 0.000 claims 7
- 229940099552 hyaluronan Drugs 0.000 claims 6
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 claims 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 4
- 229920002101 Chitin Polymers 0.000 claims 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 4
- 229940014041 hyaluronate Drugs 0.000 claims 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- 239000003102 growth factor Substances 0.000 claims 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 2
- 102100022987 Angiogenin Human genes 0.000 claims 2
- 229920000045 Dermatan sulfate Polymers 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 2
- 108010072788 angiogenin Proteins 0.000 claims 2
- 239000002639 bone cement Substances 0.000 claims 2
- 230000001413 cellular effect Effects 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 230000000925 erythroid effect Effects 0.000 claims 2
- 229930195733 hydrocarbon Natural products 0.000 claims 2
- 150000002430 hydrocarbons Chemical class 0.000 claims 2
- 239000000693 micelle Substances 0.000 claims 2
- 239000003002 pH adjusting agent Substances 0.000 claims 2
- 229960004838 phosphoric acid Drugs 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- OEANUJAFZLQYOD-CXAZCLJRSA-N (2r,3s,4r,5r,6r)-6-[(2r,3r,4r,5r,6r)-5-acetamido-3-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](OC)O[C@H](CO)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](OC)[C@H](C(O)=O)O1 OEANUJAFZLQYOD-CXAZCLJRSA-N 0.000 claims 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims 1
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims 1
- 229920002683 Glycosaminoglycan Polymers 0.000 claims 1
- 229920002971 Heparan sulfate Polymers 0.000 claims 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims 1
- 229930003268 Vitamin C Natural products 0.000 claims 1
- 229930003316 Vitamin D Natural products 0.000 claims 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims 1
- 229930003427 Vitamin E Natural products 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- 229960000583 acetic acid Drugs 0.000 claims 1
- 239000000783 alginic acid Substances 0.000 claims 1
- 229960001126 alginic acid Drugs 0.000 claims 1
- -1 alginic acid salt Chemical class 0.000 claims 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 239000011668 ascorbic acid Substances 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims 1
- 239000004568 cement Substances 0.000 claims 1
- 229910052804 chromium Inorganic materials 0.000 claims 1
- 239000011651 chromium Substances 0.000 claims 1
- 229960004106 citric acid Drugs 0.000 claims 1
- 229910017052 cobalt Inorganic materials 0.000 claims 1
- 239000010941 cobalt Substances 0.000 claims 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims 1
- 229910052802 copper Inorganic materials 0.000 claims 1
- 239000010949 copper Substances 0.000 claims 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 claims 1
- 229940051593 dermatan sulfate Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 1
- 208000013210 hematogenous Diseases 0.000 claims 1
- 229920000669 heparin Polymers 0.000 claims 1
- 229960002897 heparin Drugs 0.000 claims 1
- 229960000443 hydrochloric acid Drugs 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims 1
- 210000003593 megakaryocyte Anatomy 0.000 claims 1
- 229910052750 molybdenum Inorganic materials 0.000 claims 1
- 239000011733 molybdenum Substances 0.000 claims 1
- 229940074355 nitric acid Drugs 0.000 claims 1
- 229910017604 nitric acid Inorganic materials 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 229910052711 selenium Inorganic materials 0.000 claims 1
- 239000011669 selenium Substances 0.000 claims 1
- 229910052710 silicon Inorganic materials 0.000 claims 1
- 239000010703 silicon Substances 0.000 claims 1
- 229910052712 strontium Inorganic materials 0.000 claims 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims 1
- 235000019155 vitamin A Nutrition 0.000 claims 1
- 239000011719 vitamin A Substances 0.000 claims 1
- 235000019156 vitamin B Nutrition 0.000 claims 1
- 239000011720 vitamin B Substances 0.000 claims 1
- 235000019154 vitamin C Nutrition 0.000 claims 1
- 239000011718 vitamin C Substances 0.000 claims 1
- 235000019166 vitamin D Nutrition 0.000 claims 1
- 239000011710 vitamin D Substances 0.000 claims 1
- 150000003710 vitamin D derivatives Chemical class 0.000 claims 1
- 235000019165 vitamin E Nutrition 0.000 claims 1
- 229940046009 vitamin E Drugs 0.000 claims 1
- 239000011709 vitamin E Substances 0.000 claims 1
- 229940045997 vitamin a Drugs 0.000 claims 1
- 229940046001 vitamin b complex Drugs 0.000 claims 1
- 229940046008 vitamin d Drugs 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3514108P | 2008-03-10 | 2008-03-10 | |
| PCT/US2009/036673 WO2009114535A2 (en) | 2008-03-10 | 2009-03-10 | Bone paste composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011513034A JP2011513034A (ja) | 2011-04-28 |
| JP2011513034A5 true JP2011513034A5 (enExample) | 2012-05-10 |
Family
ID=41053827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010550818A Pending JP2011513034A (ja) | 2008-03-10 | 2009-03-10 | 骨セメント組成物 |
Country Status (4)
| Country | Link |
|---|---|
| US (3) | US8470369B2 (enExample) |
| EP (1) | EP2257163A4 (enExample) |
| JP (1) | JP2011513034A (enExample) |
| WO (1) | WO2009114535A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110118850A1 (en) * | 2008-12-13 | 2011-05-19 | Amit Prakash Govil | Bioactive Grafts and Composites |
| US12377189B2 (en) | 2008-12-13 | 2025-08-05 | Bioventus Llc | Osteoinductive bone implant including harvested demineralized bone and bone morphogenetic proteins bound thereto obtained from the same donor |
| WO2011071766A2 (en) | 2009-12-13 | 2011-06-16 | Amit Prakash Govil | Bioactive grafts and composites |
| ES2855151T3 (es) * | 2008-12-13 | 2021-09-23 | Bioventus Llc | Método de fabricación de implantes de hueso osteoinductivos |
| US8936804B2 (en) | 2010-01-15 | 2015-01-20 | Rutgers, The State University Of New Jersey | Use of vanadium compounds to accelerate bone healing |
| US20140322292A1 (en) | 2010-12-10 | 2014-10-30 | Rutgers, The State University Of New Jersey | Insulin-mimetics as therapeutic adjuncts for bone regeneration |
| WO2013006798A1 (en) | 2011-07-06 | 2013-01-10 | University Of Medicine And Dentistry Of New Jersey | Vandium compounds as therapeutic adjuncts for cartilage regeneration and repair |
| WO2013082295A1 (en) * | 2011-11-29 | 2013-06-06 | University Of Medicine And Dentistry Of New Jersey | Insulin-mimetics as therapeutic adjuncts for bone regeneration |
| JP2015534850A (ja) * | 2012-10-25 | 2015-12-07 | ラトガース，ザ ステート ユニバーシティ オブ ニュー ジャージー | 脊椎固定を促進するためのインスリン−疑似局所治療補助剤 |
| AU2014235352B2 (en) | 2013-03-15 | 2017-04-27 | Arteriocyte Medical Systems, Inc. | Compositions of and methods for cancellous bone matrix |
| CA2923002C (en) * | 2013-09-02 | 2022-12-13 | Muffin Incorporated | Products comprising an extracellular matrix tissue material and osteogenic protein |
| US9192574B2 (en) | 2013-10-24 | 2015-11-24 | Medtronic Xomed, Inc. | Chitosan paste wound dressing |
| US9192692B2 (en) | 2013-10-24 | 2015-11-24 | Medtronic Xomed, Inc. | Chitosan stenting paste |
| EP3297694A1 (en) | 2015-05-21 | 2018-03-28 | Musculoskeletal Transplant Foundation | Modified demineralized cortical bone fibers |
| WO2019097885A1 (ja) * | 2017-11-16 | 2019-05-23 | 三菱電機株式会社 | 全熱交換素子および全熱交換器 |
| CN108144047A (zh) * | 2017-12-30 | 2018-06-12 | 广州润虹医药科技股份有限公司 | 一种增加骨密度的含壳聚糖的保健组合物及其用途 |
| CN110644076B (zh) * | 2019-09-17 | 2021-10-26 | 南通大学 | 一种表面接枝重组表皮生长因子纳米纤维的制备方法 |
| CN116643054B (zh) * | 2023-06-02 | 2025-04-29 | 中国医科大学附属盛京医院 | 一种非综合征型唇腭裂产前无创诊断分子标志物c3蛋白及其应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2215209B (en) | 1988-03-14 | 1992-08-26 | Osmed Inc | Method and apparatus for biodegradable, osteogenic, bone graft substitute device |
| CA2062659A1 (en) * | 1991-03-12 | 1992-09-13 | Yasutaka Igari | Composition for sustained-release of erythropoietin |
| US5563124A (en) | 1991-04-22 | 1996-10-08 | Intermedics Orthopedics/ Denver, Inc. | Osteogenic product and process |
| US5837258A (en) | 1991-08-30 | 1998-11-17 | University Of South Florida | Induction of tissue, bone or cartilage formation using connective tissue growth factor |
| FR2706768B1 (enExample) | 1993-05-13 | 1995-12-01 | Inoteb | |
| TW369414B (en) | 1994-09-30 | 1999-09-11 | Yamanouchi Pharma Co Ltd | Bone formation transplant |
| US20030147860A1 (en) * | 2002-02-07 | 2003-08-07 | Marchosky J. Alexander | Compositions and methods for forming and strengthening bone |
| IT1302534B1 (it) * | 1998-12-21 | 2000-09-05 | Fidia Advanced Biopolymers Srl | Composizioni iniettabili, biocompatibili e biodegradabili comprendentialmeno un derivato dell'acido ialuronico, cellule condrogeniche, per |
| EP1203074A4 (en) * | 1999-06-29 | 2003-09-10 | J Alexander Marchosky | BONE FORMATION AND STRENGTHENING COMPOSITIONS AND METHOD |
| US20050255545A1 (en) | 2002-02-01 | 2005-11-17 | Smith Timothy J | Regulation of human hematopoietin receptor-like protein |
| WO2005046746A2 (en) * | 2003-11-10 | 2005-05-26 | Angiotech International Ag | Medical implants and fibrosis-inducing agents |
| PT1699915E (pt) * | 2003-12-30 | 2010-08-31 | Augustinus Bader | Utilização de eritropoietina para a regeneração de tecido hepático |
| US7691105B2 (en) * | 2005-09-26 | 2010-04-06 | Depuy Spine, Inc. | Tissue augmentation, stabilization and regeneration technique |
| US9011930B2 (en) | 2006-05-01 | 2015-04-21 | Zycal Bioceuticals Healthcare Company, Inc. | Nutritional supplement and use thereof |
-
2009
- 2009-03-10 WO PCT/US2009/036673 patent/WO2009114535A2/en not_active Ceased
- 2009-03-10 US US12/401,320 patent/US8470369B2/en not_active Expired - Fee Related
- 2009-03-10 JP JP2010550818A patent/JP2011513034A/ja active Pending
- 2009-03-10 EP EP09719893A patent/EP2257163A4/en not_active Withdrawn
-
2013
- 2013-06-25 US US13/926,444 patent/US9610304B2/en not_active Expired - Fee Related
-
2017
- 2017-04-04 US US15/478,590 patent/US20170333485A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011513034A5 (enExample) | ||
| Lomartire et al. | Algal phycocolloids: Bioactivities and pharmaceutical applications | |
| Silva et al. | Materials of marine origin: a review on polymers and ceramics of biomedical interest | |
| CA2712527C (en) | Chitosan gel for dermatological use, production method and use of same | |
| ES2368307B1 (es) | Hidrogeles elaborados a base de polímeros aniónicos de origen natural. | |
| Qamar et al. | Carrageenan‐based hybrids with biopolymers and nano‐structured materials for biomimetic applications | |
| JP2019069238A5 (enExample) | ||
| McReynolds et al. | Green in the deep blue: deep eutectic solvents as versatile systems for the processing of marine biomass | |
| Jabeen et al. | Carrageenan: structure, properties and applications with special emphasis on food science | |
| WO2010136694A3 (fr) | Hydrogel injectable permettant une supplementation en glycerol dans la peau sur le long terme | |
| WO2006062792A3 (en) | Hydrocolloids and process therefor | |
| US20100008869A1 (en) | Method for preventing coloration of catechins and dentifrice composition | |
| WO2008097842A3 (en) | Ingredient systems comprising trehalose, food products containing trehalose, and methods of making same | |
| ATE548393T1 (de) | Mischungen von aus heparin hergestellten oligosacchariden, deren herstellung und diese enthaltenden pharmazeutischen zusammensetzungen | |
| RU2015135629A (ru) | Создание профиля контролируемого высвобождения лекарственного вещества при использовании липосомной композиции в водных и безводных растворах | |
| CN111035801A (zh) | 银纳米团簇基壳聚糖水凝胶敷料及其制备方法和应用 | |
| EP2766424B1 (en) | Synthesis of an injectable multiphasic gel containing free and cross-linked monophasic hyaluronic acid and biphasic hyaluronic acid combined with hydroxyapatite with microencapsulated hyaluronidase inhibitor. | |
| Amirthalingam et al. | Perspectives and challenges of using chitosan in various biological applications | |
| James et al. | Nanotechnology-driven improvisation of red algae-derived carrageenan for industrial and bio-medical applications | |
| RU2007122799A (ru) | Хитозановые композиции | |
| JP6120397B2 (ja) | キトサン及びヒアルロナンを含むナノ粒子の製造方法 | |
| RU2015140996A (ru) | Топическая противомикробная дерматологическая композиция | |
| CA2529441A1 (en) | Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas | |
| Paczkowska-Walendowska et al. | Novel Applications of Natural Biomaterials in Dentistry—Properties, Uses, and Development Perspectives | |
| Thi My Tran et al. | Perspectives of engineered marine derived polymers for biomedical nanoparticles |